J W Olney, N B Farber. Arch Gen Psychiatry 1995
Times Cited: 1283
Times Cited: 1283
Times Cited
Times Co-cited
Similarity
Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
D C Javitt, S R Zukin. Am J Psychiatry 1991
27
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Kate Merritt, Alice Egerton, Matthew J Kempton, Matthew J Taylor, Philip K McGuire. JAMA Psychiatry 2016
Kate Merritt, Alice Egerton, Matthew J Kempton, Matthew J Taylor, Philip K McGuire. JAMA Psychiatry 2016
22
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
19
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Mariana Azcárraga, Sylvana Stephano, Rafael Favila, Leonardo Díaz-Galvis, Patricia Alvarado-Alanis, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. JAMA Psychiatry 2013
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Mariana Azcárraga, Sylvana Stephano, Rafael Favila, Leonardo Díaz-Galvis, Patricia Alvarado-Alanis, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. JAMA Psychiatry 2013
16
Glutamate and dopamine in schizophrenia: an update for the 21st century.
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
16
From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.
Bita Moghaddam, Daniel Javitt. Neuropsychopharmacology 2012
Bita Moghaddam, Daniel Javitt. Neuropsychopharmacology 2012
15
The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
15
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE).
A Egerton, B V Broberg, N Van Haren, K Merritt, G J Barker, D J Lythgoe, R Perez-Iglesias, L Baandrup, S W Düring, K V Sendt,[...]. Mol Psychiatry 2018
A Egerton, B V Broberg, N Van Haren, K Merritt, G J Barker, D J Lythgoe, R Perez-Iglesias, L Baandrup, S W Düring, K V Sendt,[...]. Mol Psychiatry 2018
21
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
15
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Anouk Marsman, Martijn P van den Heuvel, Dennis W J Klomp, René S Kahn, Peter R Luijten, Hilleke E Hulshoff Pol. Schizophr Bull 2013
Anouk Marsman, Martijn P van den Heuvel, Dennis W J Klomp, René S Kahn, Peter R Luijten, Hilleke E Hulshoff Pol. Schizophr Bull 2013
14
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Lawrence S Kegeles, Xiangling Mao, Arielle D Stanford, Ragy Girgis, Najate Ojeil, Xiaoyan Xu, Roberto Gil, Mark Slifstein, Anissa Abi-Dargham, Sarah H Lisanby,[...]. Arch Gen Psychiatry 2012
Lawrence S Kegeles, Xiangling Mao, Arielle D Stanford, Ragy Girgis, Najate Ojeil, Xiaoyan Xu, Roberto Gil, Mark Slifstein, Anissa Abi-Dargham, Sarah H Lisanby,[...]. Arch Gen Psychiatry 2012
12
Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.
Nina V Kraguljac, David M White, Meredith A Reid, Adrienne C Lahti. JAMA Psychiatry 2013
Nina V Kraguljac, David M White, Meredith A Reid, Adrienne C Lahti. JAMA Psychiatry 2013
12
Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies.
Alice Egerton, Akarmi Bhachu, Kate Merritt, Grant McQueen, Agata Szulc, Philip McGuire. Front Psychiatry 2017
Alice Egerton, Akarmi Bhachu, Kate Merritt, Grant McQueen, Agata Szulc, Philip McGuire. Front Psychiatry 2017
30
NMDA receptor hypofunction model of schizophrenia.
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
12
Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.
N V Kraguljac, M A Frölich, S Tran, D M White, N Nichols, A Barton-McArdle, M A Reid, M S Bolding, A C Lahti. Mol Psychiatry 2017
N V Kraguljac, M A Frölich, S Tran, D M White, N Nichols, A Barton-McArdle, M A Reid, M S Bolding, A C Lahti. Mol Psychiatry 2017
17
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
A C Lahti, B Koffel, D LaPorte, C A Tamminga. Neuropsychopharmacology 1995
A C Lahti, B Koffel, D LaPorte, C A Tamminga. Neuropsychopharmacology 1995
11
Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.
Nathan L Hutcheson, Meredith A Reid, David M White, Nina V Kraguljac, Kathy B Avsar, Mark S Bolding, Robert C Knowlton, Jan A den Hollander, Adrienne C Lahti. Schizophr Res 2012
Nathan L Hutcheson, Meredith A Reid, David M White, Nina V Kraguljac, Kathy B Avsar, Mark S Bolding, Robert C Knowlton, Jan A den Hollander, Adrienne C Lahti. Schizophr Res 2012
18
Effects of ketamine in normal and schizophrenic volunteers.
A C Lahti, M A Weiler, B A Tamara Michaelidis, A Parwani, C A Tamminga. Neuropsychopharmacology 2001
A C Lahti, M A Weiler, B A Tamara Michaelidis, A Parwani, C A Tamminga. Neuropsychopharmacology 2001
10
GABAergic interneuron origin of schizophrenia pathophysiology.
Kazu Nakazawa, Veronika Zsiros, Zhihong Jiang, Kazuhito Nakao, Stefan Kolata, Shuqin Zhang, Juan E Belforte. Neuropharmacology 2012
Kazu Nakazawa, Veronika Zsiros, Zhihong Jiang, Kazuhito Nakao, Stefan Kolata, Shuqin Zhang, Juan E Belforte. Neuropharmacology 2012
10
The dopamine hypothesis of schizophrenia: version III--the final common pathway.
Oliver D Howes, Shitij Kapur. Schizophr Bull 2009
Oliver D Howes, Shitij Kapur. Schizophr Bull 2009
10
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.
J M Stone, C Dietrich, R Edden, M A Mehta, S De Simoni, L J Reed, J H Krystal, D Nutt, G J Barker. Mol Psychiatry 2012
J M Stone, C Dietrich, R Edden, M A Mehta, S De Simoni, L J Reed, J H Krystal, D Nutt, G J Barker. Mol Psychiatry 2012
10
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Meredith A Reid, Nouha Salibi, David M White, Timothy J Gawne, Thomas S Denney, Adrienne C Lahti. Schizophr Bull 2019
Meredith A Reid, Nouha Salibi, David M White, Timothy J Gawne, Thomas S Denney, Adrienne C Lahti. Schizophr Bull 2019
15
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Rafael Favila, Sylvana Stephano, David Mamo, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. Neuropsychopharmacology 2011
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Rafael Favila, Sylvana Stephano, David Mamo, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. Neuropsychopharmacology 2011
9
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Daniel C Javitt. Int Rev Neurobiol 2007
Daniel C Javitt. Int Rev Neurobiol 2007
9
Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.
Scott A Schobel, Nashid H Chaudhury, Usman A Khan, Beatriz Paniagua, Martin A Styner, Iris Asllani, Benjamin P Inbar, Cheryl M Corcoran, Jeffrey A Lieberman, Holly Moore,[...]. Neuron 2013
Scott A Schobel, Nashid H Chaudhury, Usman A Khan, Beatriz Paniagua, Martin A Styner, Iris Asllani, Benjamin P Inbar, Cheryl M Corcoran, Jeffrey A Lieberman, Holly Moore,[...]. Neuron 2013
9
Reviewing the ketamine model for schizophrenia.
Joel Frohlich, John D Van Horn. J Psychopharmacol 2014
Joel Frohlich, John D Van Horn. J Psychopharmacol 2014
9
RETRACTED: Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction.
Nina Vanessa Kraguljac, Matthew Carle, Michael A Frölich, Steve Tran, Michael A Yassa, David Matthew White, Abhishek Reddy, Adrienne Carol Lahti. Biol Psychiatry Cogn Neurosci Neuroimaging 2018
Nina Vanessa Kraguljac, Matthew Carle, Michael A Frölich, Steve Tran, Michael A Yassa, David Matthew White, Abhishek Reddy, Adrienne Carol Lahti. Biol Psychiatry Cogn Neurosci Neuroimaging 2018
33
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Nina Vanessa Kraguljac, Meredith Reid, David White, Rebecca Jones, Jan den Hollander, Deborah Lowman, Adrienne Carol Lahti. Psychiatry Res 2012
Nina Vanessa Kraguljac, Meredith Reid, David White, Rebecca Jones, Jan den Hollander, Deborah Lowman, Adrienne Carol Lahti. Psychiatry Res 2012
8
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies.
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, Yukiko Mihashi, Fernando Caravaggio, Jun Ku Chung, Julia Kim, Philip Gerretsen, Masaru Mimura, Gary Remington,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2018
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, Yukiko Mihashi, Fernando Caravaggio, Jun Ku Chung, Julia Kim, Philip Gerretsen, Masaru Mimura, Gary Remington,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2018
25
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.
Houman Homayoun, Bita Moghaddam. J Neurosci 2007
Houman Homayoun, Bita Moghaddam. J Neurosci 2007
8
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.
Alice Egerton, James M Stone, Christopher A Chaddock, Gareth J Barker, Ilaria Bonoldi, Rachel M Howard, Kate Merritt, Paul Allen, Oliver D Howes, Robin M Murray,[...]. Neuropsychopharmacology 2014
Alice Egerton, James M Stone, Christopher A Chaddock, Gareth J Barker, Ilaria Bonoldi, Rachel M Howard, Kate Merritt, Paul Allen, Oliver D Howes, Robin M Murray,[...]. Neuropsychopharmacology 2014
12
The dysconnection hypothesis (2016).
Karl Friston, Harriet R Brown, Jakob Siemerkus, Klaas E Stephan. Schizophr Res 2016
Karl Friston, Harriet R Brown, Jakob Siemerkus, Klaas E Stephan. Schizophr Res 2016
7
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.
Meredith A Reid, Luke E Stoeckel, David M White, Kathy B Avsar, Mark S Bolding, N Shastry Akella, Robert C Knowlton, Jan A den Hollander, Adrienne C Lahti. Biol Psychiatry 2010
Meredith A Reid, Luke E Stoeckel, David M White, Kathy B Avsar, Mark S Bolding, N Shastry Akella, Robert C Knowlton, Jan A den Hollander, Adrienne C Lahti. Biol Psychiatry 2010
7
Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Juan R Bustillo, Thomas Jones, Hongji Chen, Nicholas Lemke, Christopher Abbott, Clifford Qualls, Shannon Stromberg, Jose Canive, Charles Gasparovic. Schizophr Bull 2017
Juan R Bustillo, Thomas Jones, Hongji Chen, Nicholas Lemke, Christopher Abbott, Clifford Qualls, Shannon Stromberg, Jose Canive, Charles Gasparovic. Schizophr Bull 2017
23
Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Eline M P Poels, Lawrence S Kegeles, Joshua T Kantrowitz, Daniel C Javitt, Jeffrey A Lieberman, Anissa Abi-Dargham, Ragy R Girgis. Schizophr Res 2014
Eline M P Poels, Lawrence S Kegeles, Joshua T Kantrowitz, Daniel C Javitt, Jeffrey A Lieberman, Anissa Abi-Dargham, Ragy R Girgis. Schizophr Res 2014
7
7
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
John H Krystal, D Cyril D'Souza, Daniel Mathalon, Edward Perry, Aysenil Belger, Ralph Hoffman. Psychopharmacology (Berl) 2003
John H Krystal, D Cyril D'Souza, Daniel Mathalon, Edward Perry, Aysenil Belger, Ralph Hoffman. Psychopharmacology (Berl) 2003
7
Cortical inhibitory neurons and schizophrenia.
David A Lewis, Takanori Hashimoto, David W Volk. Nat Rev Neurosci 2005
David A Lewis, Takanori Hashimoto, David W Volk. Nat Rev Neurosci 2005
7
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
David A Lewis, Allison A Curley, Jill R Glausier, David W Volk. Trends Neurosci 2012
David A Lewis, Allison A Curley, Jill R Glausier, David W Volk. Trends Neurosci 2012
7
Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review.
James M Stone, Paul D Morrison, Lyn S Pilowsky. J Psychopharmacol 2007
James M Stone, Paul D Morrison, Lyn S Pilowsky. J Psychopharmacol 2007
7
Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk.
Junjie Wang, Yingying Tang, Tianhong Zhang, Huiru Cui, Lihua Xu, Botao Zeng, Yu Li, Gaiying Li, Chunbo Li, Hui Liu,[...]. Neural Plast 2016
Junjie Wang, Yingying Tang, Tianhong Zhang, Huiru Cui, Lihua Xu, Botao Zeng, Yu Li, Gaiying Li, Chunbo Li, Hui Liu,[...]. Neural Plast 2016
30
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
7
Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.
Bita Moghaddam, John H Krystal. Schizophr Bull 2012
Bita Moghaddam, John H Krystal. Schizophr Bull 2012
7
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Tatsunobu Natsubori, Hideyuki Inoue, Osamu Abe, Yosuke Takano, Norichika Iwashiro, Yuta Aoki, Shinsuke Koike, Noriaki Yahata, Masaki Katsura, Wataru Gonoi,[...]. Schizophr Bull 2014
Tatsunobu Natsubori, Hideyuki Inoue, Osamu Abe, Yosuke Takano, Norichika Iwashiro, Yuta Aoki, Shinsuke Koike, Noriaki Yahata, Masaki Katsura, Wataru Gonoi,[...]. Schizophr Bull 2014
8
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.
James M Stone, Fern Day, Helen Tsagaraki, Isabel Valli, Mary A McLean, David J Lythgoe, Ruth L O'Gorman, Gareth J Barker, Philip K McGuire. Biol Psychiatry 2009
James M Stone, Fern Day, Helen Tsagaraki, Isabel Valli, Mary A McLean, David J Lythgoe, Ruth L O'Gorman, Gareth J Barker, Philip K McGuire. Biol Psychiatry 2009
7
Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.
B Moghaddam, B Adams, A Verma, D Daly. J Neurosci 1997
B Moghaddam, B Adams, A Verma, D Daly. J Neurosci 1997
7
Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis.
A Egerton, G Modinos, D Ferrera, P McGuire. Transl Psychiatry 2017
A Egerton, G Modinos, D Ferrera, P McGuire. Transl Psychiatry 2017
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.